Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antibody-dependent cellular cytotoxicity in multiple sclerosis

P Mar

    Journal of the Neurological Sciences
    |August 1, 1980
    PubMed
    Summary

    Multiple sclerosis (MS) patients exhibit heightened antibody-dependent cellular cytotoxicity (ADCC) against glial cells, indicating a specific immune response. This gliotoxic ADCC activity correlates with disease severity and progression in MS.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Decision support for clinical trial eligibility determination in breast cancer.

    Proceedings. AMIA Symposium·1999
    Same author

    Antigen receptor rearrangement and expression in acute leukemias.

    Haematology and blood transfusion·1990
    Same author

    Quantitative tracing of mRNAs for T- and B-lymphocyte receptor genes in individual cells by in situ hybridization with fluorochrome-labeled gene probes. I. Expression in malignancies carrying B-lineage associated antigens.

    Blood·1989
    Same author

    [A longitudinal study of immunological parameters in multiple sclerosis (author's transl)].

    Der Nervenarzt·1980
    Same author

    A longitudinal study of immunological parameters in multiple sclerosis: cell-mediated immunity and complement profiles.

    Clinical and experimental immunology·1979
    Same author

    A longitudinal study of immunological parameters in multiple sclerosis. Cytotoxic antibodies.

    Journal of the neurological sciences·1979

    Area of Science:

    • Neuroimmunology
    • Cellular Immunology

    Background:

    • Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system.
    • The role of specific immune mechanisms in MS pathogenesis remains under investigation.

    Purpose of the Study:

    • To investigate the presence and specificity of antibody-dependent cellular cytotoxicity (ADCC) in multiple sclerosis (MS) patients.
    • To correlate gliotoxic ADCC activity with disease severity and clinical status in MS.

    Main Methods:

    • Assessed antibody-dependent cellular cytotoxicity (ADCC) using rat glial tumor cells (CCL 107/C6) and mononuclear leukocytes from MS patients and healthy controls.
    • Evaluated ADCC activity against non-glial cells (human lung fibroblasts, HeLa cells) to determine tissue specificity.
    • Correlated ADCC activity levels with clinical disability scores and disease progression in MS patients.

    Main Results:

    • MS patients demonstrated significantly higher gliotoxic ADCC activity compared to healthy individuals and patients with other neurological diseases.
    • MS-mediated ADCC was specific for glial cells, with minimal activity against fibroblasts or HeLa cells.
    • Gliotoxic ADCC activity was positively correlated with MS disability and was most pronounced in patients with chronic progressive MS.

    Conclusions:

    • Elevated and glial-specific ADCC is a characteristic feature of multiple sclerosis.
    • This immune mechanism may play a role in MS pathogenesis and its progression.
    • ADCC activity serves as a potential biomarker for disease severity in MS.

    Related Experiment Videos